Search Results - "Jimenez, Teri"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

    Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus by Furie, Richard A, Bruce, Ian N, Dörner, Thomas, Leon, Manuel Gustavo, Leszczyński, Piotr, Urowitz, Murray, Haier, Birgit, Jimenez, Teri, Brittain, Claire, Liu, Jiajun, Barbey, Catherine, Stach, Christian

    Published in Rheumatology (Oxford, England) (03-11-2021)
    “…To evaluate the dose-response, efficacy and safety of dapirolizumab pegol (DZP) in patients with SLE. Adults with moderately to severely active SLE (SLEDAI-2K…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease

    Long-term, open-label, safety study of once-daily ropinirole extended/prolonged release in early and advanced Parkinson's disease by Makumi, Clare W., Asgharian, Afsaneh, Ellis, Jeffrey, Shaikh, Soraya, Jimenez, Teri, VanMeter, Susan

    Published in International journal of neuroscience (02-01-2016)
    “…Long-term safety of once-daily ropinirole extended/prolonged release (ropinirole XL/PR) was evaluated in subjects with early and advanced Parkinson's disease…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: